Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation
{{custom_author.name}}, {{article.zuoZheEn}}
Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation
[{{custom_ref.label}}] |
{{custom_citation.content}}
CrossRef
ADS
Pubmed
arXiv
Google scholar
|
/
〈 | 〉 |